Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze PRQR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate PRQR investment potential.

What is PRQR stock price today?

Get real-time PRQR stock price, historical data, and price charts on Financhill. Track PRQR performance with our advanced analysis tools.

Is PRQR a good investment?

Evaluate PRQR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy PRQR stock?

To buy PRQR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of PRQR?

View detailed market capitalization data and company valuation metrics for PRQR on our comprehensive analysis page.

What is the P/E ratio of PRQR?

Use our fundamental analysis tools to view PRQR P/E ratio and compare valuation metrics with industry peers.

What are PRQR earnings?

View PRQR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

ProQR Therapeutics NV 10K Form

Sell

PRQR
ProQR Therapeutics NV

Last Price:

$2.13

Seasonality Move:

13.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRQR News And Ratings

See the #1 stock for the next 7 days that we like better than PRQR

PRQR Financial Statistics

Sales & Book Value

Annual Sales:	$20.4M
Cash Flow:	$-15.4M
Price / Cash Flow:	0
Annual Sales:	$0.64
Price / Book:	3.16

Profitability

EPS (TTM):	-0.45670
Net Income (TTM):	$-47.2M
Gross Margin:	$17.5M
Return on Equity:	-67.34%
Return on Assets:	-30.87%

ProQR Therapeutics NV Earnings Forecast

Key ProQR Therapeutics NV Financial Ratios

The Gross Profit Margin over the past 7 years for PRQR is 85.40%.
The Selling, General & Administrative Expenses for PRQR have been equal to 72.26% of Gross Profit Margin.
The Research & Development expenses have been 179.98% of Revenue.
The Net Earning history of PRQR is -146.86% of Total Revenues.
Per Share Earnings over the last 12 years have been positive in 6 years.

ProQR Therapeutics NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	PRQR
CUSIP:	N71542
Website:	proqr-tx.com

Debt

Debt-to-Equity Ratio:	0.26
Current Ratio:	3.36
Quick Ratio:	3.23

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

PRQR Technical Analysis vs Fundamental Analysis